Zhong-ying Ma
Department Of Chemical Biology And Tianjin Key Laboratory Of Technologies Enabling Development Of Clinical Therapeutics And Diagnostics
Tianjin, 300070, China
Tianjin, 300070, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Pt(iv) derivatives of cisplatin and oxaliplatin bearing an EMT-related TMEM16A/COX-2-selective dual inhibitor against colorectal cancer cells HCT116.
Journal: RSC medicinal chemistry
Published: May 07, 2024
Ketoplatin in triple-negative breast cancer cells MDA-MB-231: High efficacy and low toxicity, and positive impact on inflammatory microenvironment.
Journal: Biochemical pharmacology
Published: December 03, 2020
Anticancer Melatplatin Prodrugs: High Effect and Low Toxicity, MT1-ER-Target and Immune Response In Vivo.
Journal: Journal of medicinal chemistry
Published: May 14, 2020
Fuplatin: An Efficient and Low-Toxic Dual-Prodrug.
Journal: Journal of medicinal chemistry
Published: April 20, 2019
New NSAID-Pt(IV) prodrugs to suppress metastasis and invasion of tumor cells and enhance anti-tumor effect in vitro and in vivo.
Journal: European journal of medicinal chemistry
Published: December 11, 2018
Chlorambucil-conjugated platinum(IV) prodrugs to treat triple-negative breast cancer in vitro and in vivo.
Journal: European journal of medicinal chemistry
Published: February 01, 2018
Biological evaluation of a cytotoxic 2-substituted benzimidazole copper(II) complex: DNA damage, antiproliferation and apoptotic induction activity in human cervical cancer cells.
Journal: Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine
Published: September 29, 2013
Activities of a novel Schiff base copper(II) complex on growth inhibition and apoptosis induction toward MCF-7 human breast cancer cells via mitochondrial pathway.
Journal: Journal of inorganic biochemistry
Published: January 26, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026